Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug2400 | MinnRAP Peer Support Program Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D015775 | Fractures, Stress NIH | 0.71 |
D000068376 | Compassion Fatigue NIH | 0.71 |
D000067073 | Psychological Trauma NIH | 0.58 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The hypothesis is that from a cluster defined by a confirmed positive case of COVID-19 and its contact cases, it is possible to study the different expressions and clinical evolutions of COVID-19 infection and to explore the biological profiles related to the observed clinical history. Certain biological determinants (virological, immunological, microbological or gentic) could indeed be correlated with the clinical presentation and/or be useful for personalized care. The main objective is to study the relationship between the biological profiles observed and the clinical evolutions within the same cluster of transmission of the coronavirus SARS-CoV-2 (positive COVID-19 cases and contact subjects).
Description: Nasopharyngeal SARS-CoV-2 viral load at day 0 by RT-PCR (in log or ΔCT)
Measure: Virological profile Time: Day 0Description: Nasopharyngeal SARS-CoV-2 viral load at day 0 by RT-PCR (in log or ΔCT)
Measure: Virological profile Time: Day 10Description: Nasopharyngeal SARS-CoV-2 viral load at day 0 by RT-PCR (in log or ΔCT)
Measure: Virological profile Time: Day 21Description: SARS-CoV-2 serology by enzyme-linked immunosorbent assays or magnetic chemiluminescence enzyme immunoassay (IgG and IgM titers)
Measure: Virological profile (serology) Time: Day 0Description: SARS-CoV-2 serology by enzyme-linked immunosorbent assays or magnetic chemiluminescence enzyme immunoassay (IgG and IgM titers)
Measure: Virological profile (serology) Time: Day 10Description: SARS-CoV-2 serology by enzyme-linked immunosorbent assays or magnetic chemiluminescence enzyme immunoassay (IgG and IgM titers)
Measure: Virological profile (serology) Time: Day 21Description: cytokine panel by flow cytometry or enzyme-linked immunosorbent assay in pg/mL
Measure: Immunological profile with blood level for markers of inflammation (cytokine) Time: Day 0Description: cytokine panel by flow cytometry or enzyme-linked immunosorbent assay in pg/mL
Measure: Immunological profile with blood level for markers of inflammation (cytokine) Time: Day 10Description: cytokine panel by flow cytometry or enzyme-linked immunosorbent assay in pg/mL
Measure: Immunological profile with blood level for markers of inflammation (cytokine) Time: Day 21Description: markers on immune cell subpopulation by RT-PCR or flow cytometry in CT value or %
Measure: Immunological profile with blood level for markers of inflammation Time: Day 0Description: markers on immune cell subpopulation by RT-PCR or flow cytometry in CT value or %
Measure: Immunological profile with blood level for markers of inflammation Time: Day 10Description: markers on immune cell subpopulation by RT-PCR or flow cytometry in CT value or %
Measure: Immunological profile with blood level for markers of inflammation Time: Day 21Description: CRP in mg/l
Measure: Biochemical profile by blood dosage of CRP Time: Day 0Description: CRP in mg/l
Measure: Biochemical profile by blood dosage of CRP Time: Day 10Description: CRP in mg/l
Measure: Biochemical profile by blood dosage of CRP Time: Day 21Description: CRP in mg/l
Measure: Biochemical profile by blood dosage of CRP Time: Day 90Description: ASAT/ALAT in U/L
Measure: Biochemical profile by blood dosage of ASAT/ALAT Time: Day 0Description: ASAT/ALAT in U/L
Measure: Biochemical profile by blood dosage of ASAT/ALAT Time: Day 10Description: ASAT/ALAT in U/L
Measure: Biochemical profile by blood dosage of ASAT/ALAT Time: Day 21Description: ASAT/ALAT in U/L
Measure: Biochemical profile by blood dosage of ASAT/ALAT Time: Day 90Description: LDH in U/L
Measure: Biochemical profile by blood dosage of LDH Time: Day 0Description: LDH in U/L
Measure: Biochemical profile by blood dosage of LDH Time: Day 10Description: LDH in U/L
Measure: Biochemical profile by blood dosage of LDH Time: Day 21Description: LDH in U/L
Measure: Biochemical profile by blood dosage of LDH Time: Day 90Description: Lactate in mg/l
Measure: Biochemical profile by blood dosage of Lactate Time: Day 0Description: Lactate in mg/l
Measure: Biochemical profile by blood dosage of Lactate Time: Day 10Description: Lactate in mg/l
Measure: Biochemical profile by blood dosage of Lactate Time: Day 21Description: Lactate in mg/l
Measure: Biochemical profile by blood dosage of Lactate Time: Day 90Description: D-Dimer in µg/L
Measure: Biochemical profile by blood dosage of D-Dimer Time: Day 0Description: D-Dimer in µg/L
Measure: Biochemical profile by blood dosage of D-Dimer Time: Day 10Description: D-Dimer in µg/L
Measure: Biochemical profile by blood dosage of D-Dimer Time: Day 21Description: D-Dimer in µg/L
Measure: Biochemical profile by blood dosage of D-Dimer Time: Day 90Description: Troponin in µg/L
Measure: Biochemical profile by blood dosage of Troponin Time: Day 0Description: Troponin in µg/L
Measure: Biochemical profile by blood dosage of Troponin Time: Day 10Description: Troponin in µg/L
Measure: Biochemical profile by blood dosage of Troponin Time: Day 21Description: Troponin in µg/L
Measure: Biochemical profile by blood dosage of Troponin Time: Day 90Description: Ferritin in µg/L
Measure: Biochemical profile by blood dosage of Ferritin Time: Day 0Description: Ferritin in µg/L
Measure: Biochemical profile by blood dosage of Ferritin Time: Day 10Description: Ferritin in µg/L
Measure: Biochemical profile by blood dosage of Ferritin Time: Day 21Description: RAGE (receptor of advanced end glycation products) by enzyme-linked immunosorbent assays in pg/mg total protein
Measure: Biochemical profile by blood dosage of RAGE Time: Day 0Description: RAGE (receptor of advanced end glycation products) by enzyme-linked immunosorbent assays in pg/mg total protein
Measure: Biochemical profile by blood dosage of RAGE Time: Day 10Description: RAGE (receptor of advanced end glycation products) by enzyme-linked immunosorbent assays in pg/mg total protein
Measure: Biochemical profile by blood dosage of RAGE Time: Day 21Description: SUPAR (soluble urokinase plasminogen activator receptor) by enzyme-linked immunosorbent assays in pg/mg total protein
Measure: Biochemical profile by blood dosage of SUPAR Time: Day 0Description: SUPAR (soluble urokinase plasminogen activator receptor) by enzyme-linked immunosorbent assays in pg/mg total protein
Measure: Biochemical profile by blood dosage of SUPAR Time: Day 10Description: SUPAR (soluble urokinase plasminogen activator receptor) by enzyme-linked immunosorbent assays in pg/mg total protein
Measure: Biochemical profile by blood dosage of SUPAR Time: Day 21Description: leukocytes in Giga/L
Measure: Haematological profile by blood dosage of leukocytes Time: Day 0Description: leukocytes in Giga/L
Measure: Haematological profile by blood dosage of leukocytes Time: Day 10Description: leukocytes in Giga/L
Measure: Haematological profile by blood dosage of leukocytes Time: Day 21Description: leukocytes in Giga/L
Measure: Haematological profile by blood dosage of leukocytes Time: Day 90Description: Red blood cells in Tera/L
Measure: Haematological profile by blood dosage of Red blood cells Time: Day 0Description: Red blood cells in Tera/L
Measure: Haematological profile by blood dosage of Red blood cells Time: Day 10Description: Red blood cells in Tera/L
Measure: Haematological profile by blood dosage of Red blood cells Time: Day 21Description: Red blood cells in Tera/L
Measure: Haematological profile by blood dosage of Red blood cells Time: Day 90Description: Hemoglobin in g/dL
Measure: Haematological profile by blood dosage of Hemoglobin Time: Day 0Description: Hemoglobin in g/dL
Measure: Haematological profile by blood dosage of Hemoglobin Time: Day 10Description: Hemoglobin in g/dL
Measure: Haematological profile by blood dosage of Hemoglobin Time: Day 21Description: Hemoglobin in g/dL
Measure: Haematological profile by blood dosage of Hemoglobin Time: Day 90Description: Hematocrit in %
Measure: Haematological profile by blood dosage of Hematocrit Time: Day 0Description: Hematocrit in %
Measure: Haematological profile by blood dosage of Hematocrit Time: Day 10Description: Hematocrit in %
Measure: Haematological profile by blood dosage of Hematocrit Time: Day 21Description: Hematocrit in %
Measure: Haematological profile by blood dosage of Hematocrit Time: Day 90Description: Mean corpuscular volume in fL
Measure: Haematological profile by blood dosage of Mean corpuscular volume Time: Day 0Description: Mean corpuscular volume in fL
Measure: Haematological profile by blood dosage of Mean corpuscular volume Time: Day 10Description: Mean corpuscular volume in fL
Measure: Haematological profile by blood dosage of Mean corpuscular volume Time: Day 21Description: Mean corpuscular volume in fL
Measure: Haematological profile by blood dosage of Mean corpuscular volume Time: Day 90Description: Mean corpuscular hemoglobin in pg
Measure: Haematological profile by blood dosage of Mean corpuscular hemoglobin Time: Day 0Description: Mean corpuscular hemoglobin in pg
Measure: Haematological profile by blood dosage of Mean corpuscular hemoglobin Time: Day 10Description: Mean corpuscular hemoglobin in pg
Measure: Haematological profile by blood dosage of Mean corpuscular hemoglobin Time: Day 21Description: Mean corpuscular hemoglobin in pg
Measure: Haematological profile by blood dosage of Mean corpuscular hemoglobin Time: Day 90Description: Average corpuscular concentration of haemoglobin in g/dL
Measure: Haematological profile by blood dosage of average corpuscular concentration of haemoglobin Time: Day 0Description: Average corpuscular concentration of haemoglobin in g/dL
Measure: Haematological profile by blood dosage of average corpuscular concentration of haemoglobin Time: Day 10Description: Average corpuscular concentration of haemoglobin in g/dL
Measure: Haematological profile by blood dosage of average corpuscular concentration of haemoglobin Time: Day 21Description: Average corpuscular concentration of haemoglobin in g/dL
Measure: Haematological profile by blood dosage of average corpuscular concentration of haemoglobin Time: Day 90Description: polynuclear neutrophil in Giga/L
Measure: Haematological profile by blood dosage of polynuclear neutrophil Time: Day 0Description: polynuclear neutrophil in Giga/L
Measure: Haematological profile by blood dosage of polynuclear neutrophil Time: Day 10Description: polynuclear neutrophil in Giga/L
Measure: Haematological profile by blood dosage of polynuclear neutrophil Time: Day 21Description: polynuclear neutrophil in Giga/L
Measure: Haematological profile by blood dosage of polynuclear neutrophil Time: Day 90Description: polynuclear eosinophils in Giga/L
Measure: Haematological profile by blood dosage of polynuclear eosinophils Time: Day 0Description: polynuclear eosinophils in Giga/L
Measure: Haematological profile by blood dosage of polynuclear eosinophils Time: Day 10Description: polynuclear eosinophils in Giga/L
Measure: Haematological profile by blood dosage of polynuclear eosinophils Time: Day 21Description: polynuclear eosinophils in Giga/L
Measure: Haematological profile by blood dosage of polynuclear eosinophils Time: Day 90Description: polynuclear basophils in Giga/L
Measure: Haematological profile by blood dosage of polynuclear basophils Time: Day 0Description: polynuclear basophils in Giga/L
Measure: Haematological profile by blood dosage of polynuclear basophils Time: Day 10Description: polynuclear basophils in Giga/L
Measure: Haematological profile by blood dosage of polynuclear basophils Time: Day 21Description: polynuclear basophils in Giga/L
Measure: Haematological profile by blood dosage of polynuclear basophils Time: Day 90Description: lymphocytes in Giga/L
Measure: Haematological profile by blood dosage of lymphocytes Time: Day 0Description: lymphocytes in Giga/L
Measure: Haematological profile by blood dosage of lymphocytes Time: Day 10Description: lymphocytes in Giga/L
Measure: Haematological profile by blood dosage of lymphocytes Time: Day 21Description: lymphocytes in Giga/L
Measure: Haematological profile by blood dosage of lymphocytes Time: Day 90Description: monocytes in Giga/L
Measure: Haematological profile by blood dosage of monocytes Time: Day 90Description: monocytes in Giga/L
Measure: Haematological profile by blood dosage of monocytes Time: Day 0Description: monocytes in Giga/L
Measure: Haematological profile by blood dosage of monocytes Time: Day 10Description: monocytes in Giga/L
Measure: Haematological profile by blood dosage of monocytes Time: Day 21Description: platelets in Giga/L
Measure: Haematological profile by blood dosage of platelets Time: Day 0Description: platelets in Giga/L
Measure: Haematological profile by blood dosage of platelets Time: Day 10Description: platelets in Giga/L
Measure: Haematological profile by blood dosage of platelets Time: Day 21Description: platelets in Giga/L
Measure: Haematological profile by blood dosage of platelets Time: Day 90Description: activated partial thromboplastin time in second/witness
Measure: Haematological profile by blood dosage of activated partial thromboplastin time Time: Day 0Description: activated partial thromboplastin time in second/witness
Measure: Haematological profile by blood dosage of activated partial thromboplastin time Time: Day 10Description: activated partial thromboplastin time in second/witness
Measure: Haematological profile by blood dosage of activated partial thromboplastin time Time: Day 21Description: activated partial thromboplastin time in second/witness
Measure: Haematological profile by blood dosage of activated partial thromboplastin time Time: Day 90Description: fibrinogen in g/L
Measure: Haematological profile by blood dosage of fibrinogen Time: Day 0Description: fibrinogen in g/L
Measure: Haematological profile by blood dosage of fibrinogen Time: Day 10Description: fibrinogen in g/L
Measure: Haematological profile by blood dosage of fibrinogen Time: Day 21Description: fibrinogen in g/L
Measure: Haematological profile by blood dosage of fibrinogen Time: Day 90Description: factor V in %
Measure: Haematological profile by blood dosage of factor V Time: Day 0Description: factor V in %
Measure: Haematological profile by blood dosage of factor V Time: Day 10Description: factor V in %
Measure: Haematological profile by blood dosage of factor V Time: Day 21Description: factor V in %
Measure: Haematological profile by blood dosage of factor V Time: Day 90Description: RT-PCR SARS-CoV-2 on saliva in ΔCT value or log10 copies per mL
Measure: SARS-CoV-2 salivary viral load Time: Day 0Description: RT-PCR SARS-CoV-2 on saliva in ΔCT value or log10 copies per mL
Measure: SARS-CoV-2 salivary viral load Time: Day 10Description: RT-PCR SARS-CoV-2 on saliva in ΔCT value or log10 copies per mL
Measure: SARS-CoV-2 salivary viral load Time: Day 21Description: bioinformatic and statistical analyzes of viral sequences (arbitrary unit and p-values)
Measure: Comparison of viral sequences Time: Day 0Description: bioinformatic and statistical analyzes of viral sequences (arbitrary unit and p-values)
Measure: Comparison of viral sequences Time: Day 10Description: bioinformatic and statistical analyzes of viral sequences (arbitrary unit and p-values)
Measure: Comparison of viral sequences Time: Day 21Description: bioinformatic and statistical analyzes of microbiota (arbitrary unit and p-values)
Measure: microbiota analysis Time: Day 0Description: bioinformatic and statistical analyzes of microbiota (arbitrary unit and p-values)
Measure: microbiota analysis Time: Day 10Description: bioinformatic and statistical analyzes of microbiota (arbitrary unit and p-values)
Measure: microbiota analysis Time: Day 21Description: EPICE score (Assessment of precariousness and health inequalities in examination centers Health) at day 0 from 0 to 100
Measure: environmental and societal factors (EPICE) Time: Day 0Description: eating habits
Measure: environmental and societal factors Time: Day 0Description: eating habits
Measure: environmental and societal factors Time: day 10Description: eating habits
Measure: environmental and societal factors Time: day 21Description: eating habits
Measure: environmental and societal factors Time: day 90Description: SF-36 score (quality of life by Gardenal O) from 0 to 100
Measure: environmental and societal factors (SF-36) Time: Day 0Description: SF-36 score (quality of life by Gardenal O) from 0 to 100
Measure: environmental and societal factors (SF-36) Time: day 10Description: SF-36 score (quality of life by Gardenal O) from 0 to 100
Measure: environmental and societal factors (SF-36) Time: day 21Description: SF-36 score (quality of life by Gardenal O) from 0 to 100
Measure: environmental and societal factors (SF-36) Time: day 90Description: Physical activity score (by J. Ricci et L. Gagnon test for adults and ActiFitY test for children) from 0 to 100
Measure: environmental and societal factors (Physical activity) Time: Day 0Description: Physical activity score (by J. Ricci et L. Gagnon test for adults and ActiFitY test for children) from 0 to 100
Measure: environmental and societal factors (Physical activity) Time: day 10Description: Physical activity score (by J. Ricci et L. Gagnon test for adults and ActiFitY test for children) from 0 to 100
Measure: environmental and societal factors (Physical activity) Time: day 21Description: Physical activity score (by J. Ricci et L. Gagnon test for adults and ActiFitY test for children) from 0 to 100
Measure: environmental and societal factors (Physical activity) Time: day 90Description: body weight in kg
Measure: body weight Time: Day 0Description: body weight in kg
Measure: body weight Time: day 10Description: body weight in kg
Measure: body weight Time: day 21Description: body weight in kg
Measure: body weight Time: day 90Description: oxygen saturation in %
Measure: oxygen saturation Time: Day 0Description: oxygen saturation in %
Measure: oxygen saturation Time: day 10Description: oxygen saturation in %
Measure: oxygen saturation Time: day 21Description: oxygen saturation in %
Measure: oxygen saturation Time: day 90Description: Respiratory rate per minute
Measure: Respiratory rate Time: Day 0Description: Respiratory rate per minute
Measure: Respiratory rate Time: day 10Description: Respiratory rate per minute
Measure: Respiratory rate Time: day 21Description: Respiratory rate per minute
Measure: Respiratory rate Time: day 90Description: cardiac frequency per minute
Measure: cardiac frequency Time: Day 0Description: cardiac frequency per minute
Measure: cardiac frequency Time: day 10Description: cardiac frequency per minute
Measure: cardiac frequency Time: day 21Description: cardiac frequency per minute
Measure: cardiac frequency Time: day 90Description: Lung damage on auscultation in terms of presence/absence
Measure: lung damage Time: Day 0Description: Lung damage on auscultation in terms of presence/absence
Measure: lung damage Time: day 10Description: Lung damage on auscultation in terms of presence/absence
Measure: lung damage Time: day 21Description: Lung damage on auscultation in terms of presence/absence
Measure: lung damage Time: day 90Description: CT san in terms of normal/abnormal (children and pregnant women not concerned)
Measure: lung evolution Time: day 90Description: Dysatolic/systolic blood pressure in mmHg
Measure: blood pressure Time: Day 0Description: Dysatolic/systolic blood pressure in mmHg
Measure: blood pressure Time: day 10Description: Dysatolic/systolic blood pressure in mmHg
Measure: blood pressure Time: day 21Description: Dysatolic/systolic blood pressure in mmHg
Measure: blood pressure Time: day 90Description: Body temperature in °C
Measure: body temperature Time: Day 0Description: Body temperature in °C
Measure: body temperature Time: day 10Description: Body temperature in °C
Measure: body temperature Time: day 21Description: Body temperature in °C
Measure: body temperature Time: day 90Description: Skin mottling in terms of presence/absence
Measure: clinical exam (skin) Time: Day 0Description: Skin mottling in terms of presence/absence
Measure: clinical exam (skin) Time: day 10Description: Skin mottling in terms of presence/absence
Measure: clinical exam (skin) Time: day 21Description: Skin mottling in terms of presence/absence
Measure: clinical exam (skin) Time: day 90Description: polypnea in terms of presence/absence
Measure: clinical exam (polypnea) Time: Day 0Description: polypnea in terms of presence/absence
Measure: clinical exam (polypnea) Time: day 10Description: polypnea in terms of presence/absence
Measure: clinical exam (polypnea) Time: day 21Description: polypnea in terms of presence/absence
Measure: clinical exam (polypnea) Time: day 90Description: denutrition in terms of presence/absence
Measure: denutrition Time: Day 0Description: denutrition in terms of presence/absence
Measure: denutrition Time: day 10Description: denutrition in terms of presence/absence
Measure: denutrition Time: day 21Description: denutrition in terms of presence/absence
Measure: denutrition Time: day 90Description: Antibiotic treatment in terms of presence/absence with precision if necessary
Measure: Antibiotic treatment Time: Day 0Description: Antibiotic treatment in terms of presence/absence with precision if necessary
Measure: Antibiotic treatment Time: day 10Description: Antibiotic treatment in terms of presence/absence with precision if necessary
Measure: Antibiotic treatment Time: day 21Description: Antibiotic treatment in terms of presence/absence with precision if necessary
Measure: Antibiotic treatment Time: day 90Description: Steroidal anti-inflammatory treatment in terms of presence/absence with precision if necessary
Measure: Steroidal anti-inflammatory treatment Time: Day 0Description: Steroidal anti-inflammatory treatment in terms of presence/absence with precision if necessary
Measure: Steroidal anti-inflammatory treatment Time: day 10Description: Steroidal anti-inflammatory treatment in terms of presence/absence with precision if necessary
Measure: Steroidal anti-inflammatory treatment Time: day 21Description: Steroidal anti-inflammatory treatment in terms of presence/absence with precision if necessary
Measure: Steroidal anti-inflammatory treatment Time: day 90Description: Anti-diabetic treatment in terms of presence/absence with precision if necessary
Measure: Anti-diabetic treatment Time: Day 0Description: Anti-diabetic treatment in terms of presence/absence with precision if necessary
Measure: Anti-diabetic treatment Time: day 10Description: Anti-diabetic treatment in terms of presence/absence with precision if necessary
Measure: Anti-diabetic treatment Time: day 21Description: Anti-diabetic treatment in terms of presence/absence with precision if necessary
Measure: Anti-diabetic treatment Time: day 90Description: Gastric protector treatment in terms of presence/absence with precision if necessary
Measure: Gastric protector treatment Time: Day 0Description: Gastric protector treatment in terms of presence/absence with precision if necessary
Measure: Gastric protector treatment Time: day 10Description: Gastric protector treatment in terms of presence/absence with precision if necessary
Measure: Gastric protector treatment Time: day 21Description: Gastric protector treatment in terms of presence/absence with precision if necessary
Measure: Gastric protector treatment Time: day 90Description: chills in terms of presence/absence
Measure: chills Time: Day 0Description: chills in terms of presence/absence
Measure: chills Time: day 10Description: chills in terms of presence/absence
Measure: chills Time: day 21Description: chills in terms of presence/absence
Measure: chills Time: day 90Description: Myalgia in terms of presence/absence
Measure: Myalgia Time: Day 0Description: Myalgia in terms of presence/absence
Measure: Myalgia Time: day 10Description: Myalgia in terms of presence/absence
Measure: Myalgia Time: day 21Description: Myalgia in terms of presence/absence
Measure: Myalgia Time: day 90Description: Anorexia in terms of presence/absence
Measure: Anorexia Time: Day 0Description: Anorexia in terms of presence/absence
Measure: Anorexia Time: day 10Description: Anorexia in terms of presence/absence
Measure: Anorexia Time: day 21Description: Anorexia in terms of presence/absence
Measure: Anorexia Time: day 90Description: Rhinitis in terms of presence/absence
Measure: Rhinitis Time: Day 0Description: Rhinitis in terms of presence/absence
Measure: Rhinitis Time: day 10Description: Rhinitis in terms of presence/absence
Measure: Rhinitis Time: day 21Description: Rhinitis in terms of presence/absence
Measure: Rhinitis Time: day 90Description: Confusion in terms of presence/absence
Measure: Confusion Time: Day 0Description: Confusion in terms of presence/absence
Measure: Confusion Time: day 10Description: Confusion in terms of presence/absence
Measure: Confusion Time: day 21Description: Confusion in terms of presence/absence
Measure: Confusion Time: day 90Description: Asthenia in terms of presence/absence
Measure: Asthenia Time: Day 0Description: Asthenia in terms of presence/absence
Measure: Asthenia Time: day 10Description: Asthenia in terms of presence/absence
Measure: Asthenia Time: day 21Description: Asthenia in terms of presence/absence
Measure: Asthenia Time: day 90Description: Falls at home in terms of presence/absence
Measure: Falls at home Time: Day 0Description: Falls at home in terms of presence/absence
Measure: Falls at home Time: day 10Description: Falls at home in terms of presence/absence
Measure: Falls at home Time: day 21Description: Falls at home in terms of presence/absence
Measure: Falls at home Time: day 90Description: Insomnia in terms of presence/absence
Measure: Insomnia Time: Day 0Description: Insomnia in terms of presence/absence
Measure: Insomnia Time: day 10Description: Insomnia in terms of presence/absence
Measure: Insomnia Time: day 21Description: Insomnia in terms of presence/absence
Measure: Insomnia Time: day 90Description: Angina in terms of presence/absence
Measure: Angina Time: Day 0Description: Angina in terms of presence/absence
Measure: Angina Time: day 10Description: Angina in terms of presence/absence
Measure: Angina Time: day 21Description: Angina in terms of presence/absence
Measure: Angina Time: day 90Description: Ageusia in terms of presence/absence
Measure: Ageusia Time: Day 0Description: Ageusia in terms of presence/absence
Measure: Ageusia Time: day 10Description: Ageusia in terms of presence/absence
Measure: Ageusia Time: day 21Description: Ageusia in terms of presence/absence
Measure: Ageusia Time: day 90Description: Respiratory complaints in term of SRIpr score from 0 to 100
Measure: Respiratory complaints Time: Day 0Description: Respiratory complaints in term of SRIpr score from 0 to 100
Measure: Respiratory complaints Time: day 2Description: Respiratory complaints in term of SRIpr score from 0 to 100
Measure: Respiratory complaints Time: day 4Description: Respiratory complaints in term of SRIpr score from 0 to 100
Measure: Respiratory complaints Time: day 6Description: Respiratory complaints in term of SRIpr score from 0 to 100
Measure: Respiratory complaints Time: day 8Description: Respiratory complaints in term of SRIpr score from 0 to 100
Measure: Respiratory complaints Time: day 10Description: Respiratory complaints in term of SRIpr score from 0 to 100
Measure: Respiratory complaints Time: day 21Description: Respiratory complaints in term of SRIpr score from 0 to 100
Measure: Respiratory complaints Time: day 90Description: Rate of viral transmission determine by bioinformatic and statistical analyzes in %
Measure: transmission rate Time: Day 0Description: Rate of viral transmission determine by bioinformatic and statistical analyzes in %
Measure: transmission rate Time: day 10Description: Rate of viral transmission determine by bioinformatic and statistical analyzes in %
Measure: transmission rate Time: day 21Description: Prolonged viral shedding evaluate by RT-PCR (CT value or log10 copies per mL)
Measure: prolonged viral shedding Time: between day 0 and day 21Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports